Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05141175 · ClinicalTrials.gov registry record · NA

Tailored to You (TTY) Pilot Study

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT05141175 is a NA study that has completed, run by Duke University. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05141175, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this research study is to use a test called impedance cardiography (ICG) to provide more information about how to improve the control of blood pressure. Participants will be given this test so investigators can get more information about what is going on inside the heart and blood vessels that is contributing to high blood pressure. ICG is a lot like an EKG (electrocardiogram) in that it uses electrodes and a computer to make a report. Participants will lie down on the exam table and two electrodes go on the right ankle and two electrodes go on the left wrist. The process takes about 5 minutes and is painless and not invasive.

Interventions

  • DEVICE Hypertension medication algorithm
  • DEVICE Impedance Cardiography

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-01-10
Est. Completion 2022-06-28
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05141175

The ClinicalTrials.gov registry entry for NCT05141175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Hypertension medication algorithm is the first listed.

NCT05141175 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05141175 about?

NCT05141175 is a clinical study titled "Tailored to You (TTY) Pilot Study". The purpose of this research study is to use a test called impedance cardiography (ICG) to provide more information about how to improve the control of blood pressure. Participants will be given this test so investigators can get more information about what is going on inside the heart and blood ves...

What is the current status of trial NCT05141175?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-01-10. Estimated completion is 2022-06-28.

What interventions are being tested in trial NCT05141175?

The interventions under investigation include: Hypertension medication algorithm (DEVICE), Impedance Cardiography (DEVICE).

Who is sponsoring clinical trial NCT05141175?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.